Blackrock Japan Company LTD Trimmed Goldman Sachs Group (GS) Holding; Catalyst Pharmaceutical Partners (CPRX) Sentiment Is 1.21

August 27, 2017 - By Nellie Frank

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The company has market cap of $235.06 million. The Firm is focused on developing and commercializing therapies for people with rare debilitating diseases. It currently has negative earnings. The Firm has three drugs in development: Firdapse, CPP-109 and CPP-115.

Blackrock Japan Company Ltd decreased Goldman Sachs Group Inc (GS) stake by 2.2% reported in 2016Q4 SEC filing. Blackrock Japan Company Ltd sold 10,838 shares as Goldman Sachs Group Inc (GS)’s stock declined 13.97%. The Blackrock Japan Company Ltd holds 480,713 shares with $115.11M value, down from 491,551 last quarter. Goldman Sachs Group Inc now has $86.07 billion valuation. The stock decreased 0.23% or $0.52 on August 25, reaching $222.47. About 2.23 million shares traded. Goldman Sachs Group Inc (NYSE:GS) has risen 39.23% since August 27, 2016 and is uptrending. It has outperformed by 22.53% the S&P500.

Investors sentiment increased to 1.02 in Q4 2016. Its up 0.14, from 0.88 in 2016Q3. It increased, as 65 investors sold GS shares while 424 reduced holdings. 168 funds opened positions while 262 raised stakes. 287.95 million shares or 5.61% more from 272.65 million shares in 2016Q3 were reported. Mycio Wealth Limited Liability reported 1,673 shares. Beck Capital Management Lc stated it has 147,805 shares. Johnson Fincl Gp holds 753 shares. Suvretta Mngmt Lc reported 336,605 shares. Virginia-based Palladium Prtnrs Limited Liability has invested 0.19% in Goldman Sachs Group Inc (NYSE:GS). Riverpoint Capital Mngmt Lc has 853 shares. Fisher Asset Limited owns 1.94 million shares. The Netherlands-based Pggm Invs has invested 0.04% in Goldman Sachs Group Inc (NYSE:GS). Fmr Limited Liability Corp holds 0.32% or 9.91 million shares in its portfolio. Hennessy Advsrs holds 6,000 shares. Dearborn Ptnrs Lc invested in 923 shares or 0.02% of the stock. Conning reported 17,405 shares. Hollencrest Securities Limited Liability Co stated it has 2,196 shares. Hartline Invest Corporation stated it has 22,448 shares or 1.88% of all its holdings. Fil has invested 0.08% in Goldman Sachs Group Inc (NYSE:GS).

Blackrock Japan Company Ltd increased Blackrock Inc (NYSE:BLK) stake by 1,124 shares to 157,675 valued at $60.00 million in 2016Q4. It also upped International Business Machs (NYSE:IBM) stake by 85,597 shares and now owns 1.31M shares. Southwestern Energy Co (NYSE:SWN) was raised too.

Among 27 analysts covering Goldman Sachs Group Inc. (NYSE:GS), 12 have Buy rating, 1 Sell and 14 Hold. Therefore 44% are positive. Goldman Sachs Group Inc. had 74 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, November 8 the stock rating was downgraded by Citigroup to “Neutral”. The stock of Goldman Sachs Group Inc (NYSE:GS) has “Outperform” rating given on Thursday, August 10 by Wells Fargo. BMO Capital Markets maintained Goldman Sachs Group Inc (NYSE:GS) rating on Wednesday, August 23. BMO Capital Markets has “Hold” rating and $202.0 target. The company was upgraded on Friday, February 5 by UBS. Morgan Stanley upgraded the shares of GS in report on Monday, October 26 to “Overweight” rating. The company was maintained on Friday, October 16 by UBS. The stock of Goldman Sachs Group Inc (NYSE:GS) earned “Buy” rating by Oppenheimer on Tuesday, July 18. Berenberg initiated Goldman Sachs Group Inc (NYSE:GS) rating on Wednesday, July 13. Berenberg has “Hold” rating and $140 target. Oppenheimer maintained Goldman Sachs Group Inc (NYSE:GS) on Friday, January 29 with “Outperform” rating. The stock of Goldman Sachs Group Inc (NYSE:GS) earned “Sell” rating by Citigroup on Tuesday, January 10.

Tanaka Capital Management Inc holds 1.38% of its portfolio in Catalyst Pharmaceuticals Inc for 589,883 shares. Broadfin Capital Llc owns 8.20 million shares or 0.96% of their US portfolio. Moreover, Venbio Select Advisor Llc has 0.24% invested in the company for 1.14 million shares. The New York-based Berson & Corrado Investment Advisors Llc has invested 0.12% in the stock. Baker Bros. Advisors Lp, a New York-based fund reported 5.10 million shares.

The stock decreased 0.71% or $0.02 on August 25, reaching $2.78. About 241,636 shares traded. Catalyst Pharmaceuticals Inc (CPRX) has risen 267.48% since August 27, 2016 and is uptrending. It has outperformed by 250.78% the S&P500.